Category: Diagnostic Technologies

Diagnostic Technologies

Proscia is scaling its AI-powered Concentriq pathology platform, driving adoption through a variety of clinical and business benefits.

SeqOnce has launched Measles Panel A, a new RT-qPCR assay designed to detect all known measles genotypes—including the D8 genotype.

NGS-based MRD testing offers unprecedented sensitivity and breadth in detecting low-frequency leukemic clones.

Amsbio has launched Collagenase and Neutral Protease NB enzymes to support high-purity, regulatory-compliant tissue dissociation workflows.

Techcyte and Pramana are launching a smart, inline volumetric digital scanning technology that integrates real-time AI analysis.

Advanced Instruments' freezing point osmometer aims to streamline osmolality testing workflows with automation and enhanced efficiency.

A new diagnostic classification module for AHEAD Medicine's Cyto-Copilot platform enhances AML versus non-neoplastic classification.

Sysmex America has received FDA clearance for its CN-6000 Automated Blood Coagulation Analyzer and key hemostasis test reagents.

A real-world study at Our Lady of the Lake Regional Medical Center found Cytovale's IntelliSep test significantly reduced sepsis mortality.

Thermo Fisher Scientific unveiled advanced mass spectrometry instruments—Orbitrap Astral Zoom MS and Orbitrap Excedion Pro MS.

Bruker's MALDI Biotyper sirius and sirius one systems have received the ACT Label from My Green Lab, recognizing responsible design.

A new study reveals that a simple blood test using single-cell sequencing of rare stem cells can detect early signs of leukemia.

Researchers have developed a new bioluminescence-based diagnostic tool that offers virus detection in complex biological samples.

TOBY, Inc. has completed its participation in the prestigious Mayo Clinic and Arizona State University MedTech Accelerator.